Key result
Knockdown of ANGPTL2 protected HK-2 cells against hypoxia/reoxygenation-induced injury by improving cell viability and inhibiting oxidative stress and inflammation.
Why the study?
Renal ischemia/reperfusion injury involves oxidative stress and inflammation, and ANGPTL2 regulates kidney function, but its role in renal ischemia/reperfusion injury required evaluation.
Does knockdown of ANGPTL2 protect human proximal tubular epithelial cells against hypoxia/reoxygenation-induced injury?
Does knockdown of ANGPTL2 protect human proximal tubular epithelial cells against hypoxia/reoxygenation-induced injury?
Knockdown of ANGPTL2 protects renal tubular epithelial cells from hypoxia/reoxygenation injury by modulating oxidative stress and inflammation pathways, suggesting a potential therapeutic target for renal ischemia/reperfusion injury.
Answers are grounded in this paper and cite their sources.
Should not yet change practice in renal IRI; leaves open ANGPTL2 as a target for in vivo validation.
Renal ischemia/reperfusion (I/R) injury is a particular threat faced by clinicians in kidney transplantation. Previous studies have confirmed the importance of oxidative stress and inflammation in the pathogenesis of I/R injury. Angiopoietin-like protein 2 (ANGPTL2) belongs to the angiopoietin-like family and has been found to be involved in the regulation of kidney function as well as oxidative and inflammatory response. In the present study, we aimed to evaluate the role of ANGPTL2 in renal I/R injury in vitro. The human proximal tubular epithelial cell line (HK-2 cells) was subjected to hypoxia/ reoxygenation (H/R) to mimic I/R injury in vitro. We found that the expression level of ANGPTL2 was markedly increased in H/R-induced HK-2 cells. Knockdown of ANGPTL2 improved the decreased cell viability of HK-2 cells in response to H/R stimulation. Knockdown of ANGPTL2 significantly inhibited the H/R-caused increase in levels of reactive oxygen species, malondialdehyde, and proinflammatory cytokines, including interleukin (IL)-6, IL-1β, and tumor necrosis factor-alpha, as well as a decrease in superoxide dismutase activity in the HK-2 cells. Besides, the increased bax expression and caspase-3 activity and decreased bcl-2 expression in H/R-induced HK-2 cells were also attenuated by knockdown of ANGPTL2. Moreover, ANGPTL2 overexpression showed the opposite effects. Further mechanism investigations proved that the activation of Nrf2/HO-1 signaling pathway and the inhibition of toll-like receptor 4/nuclear factor kappa-light-chain-enhancer of activated B cells signaling pathway were both implicated in the renal-protective effects of ANGPTL2 knockdown on H/R-induced HK-2 cells. Collectively, these findings suggested that ANGPTL2 might be a new possible target for the treatment and prevention of renal I/R injury.
No takes yet. Share an insight, caveat, or question.
Xiang et al. (2020) studied Renal ischemia/reperfusion injury. Knockdown of ANGPTL2 vs. Control / ANGPTL2 overexpression was evaluated on Cell viability, oxidative stress, and inflammatory response. Knockdown of ANGPTL2 protected HK-2 cells against hypoxia/reoxygenation-induced injury by improving cell viability and inhibiting oxidative stress and inflammation.
Synapse has enriched 10 related papers. Consider them for comparative context: